KARO BIO AB
Patent Owner
Stats
- 8 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Dec 30, 2014 most recent publication
Details
- 8 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 382 Total Citation Count
- Apr 06, 1994 Earliest Filing
- 61 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7956214 Process for the preparation of aniline-derived thyroid receptor ligandsExpiredJun 15, 09Jun 07, 11[C07C]
2010/0004,271 HETEROCYCLIC COMPOUNDS AS AGANIST FOR THE THYROID RECEPTORAbandonedJul 04, 06Jan 07, 10[A61K, C07D, G01N, A61P]
2009/0326,018 2-Phenyl indene derivatives useful as estrogen receptor ligandsAbandonedOct 12, 07Dec 31, 09[A61K, C07D, C07C]
2009/0233,979 Indole Derivatives and Their Use as Thyroid Receptor LigandsAbandonedMay 24, 07Sep 17, 09[A61K, C07D]
2009/0220,598 Stable Oral Pharmaceutical Composition Containing Thyroid Hormone Receptor AgonistsAbandonedMar 27, 07Sep 03, 09[A61K]
7521439 Glucocorticoid receptor ligands for the treatment of metabolic disordersExpiredJul 21, 06Apr 21, 09[A61K]
2008/0027,096 Novel Pharmaceutical CompositionsAbandonedMar 04, 05Jan 31, 08[A61K, C07D, C07C, G01N, A61P]
7319096 Thyroid hormone receptor antagonists for cardiac and metabolic disorders IIExpiredApr 15, 02Jan 15, 08[A61K]
7319163 Thyroid receptor antagonists for the treatment of cardiac and metabolic disordersExpiredJun 24, 05Jan 15, 08[C07C]
2008/0004,251 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid ReceptorAbandonedMar 22, 05Jan 03, 08[A61K, C07C, G01N, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.